Du Ying - 11 Mar 2026 Form 4 Insider Report for Zai Lab Ltd (ZLAB)

Signature
/s/ Bruce Blefeld, Attorney-in-Fact
Issuer symbol
ZLAB
Transactions as of
11 Mar 2026
Net transactions value
$0
Form type
4
Filing time
16 Mar 2026, 16:06:23 UTC
Previous filing
12 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Du Ying Chairperson & CEO, Director C/O ZAI LAB LIMITED, 314 MAIN STREET, 4TH FLOOR, SUITE 100, CAMBRIDGE /s/ Bruce Blefeld, Attorney-in-Fact 16 Mar 2026 0001731790

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ZLAB Stock Options (Right to Buy) Award +353,430 $0.000000* 353,430 11 Mar 2026 American Depositary Shares 353,430 $19.34 Direct F1, F2
transaction ZLAB Restricted Share Units Award +32,419 $0.000000* 32,419 11 Mar 2026 American Depositary Shares 32,419 Direct F1, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each American Depositary Share ("ADS") represents ten Ordinary Shares of the issuer. Our ADSs and Ordinary Shares are fully fungible. For purposes of this Form 4, we are reporting this in terms of ADSs.
F2 The option vests in equal annual installments over four years beginning on 03/11/2027, the first anniversary of the date of grant, subject to continuous service.
F3 Each Restricted Share Unit ("RSU") represents a contingent right to receive one ADS.
F4 The RSUs vest in equal annual installments over four years beginning on 03/11/2027, the first anniversary of the date of grant, subject to continuous service. Vested shares will be delivered in the form of ADSs to the reporting person following vesting.